Dorothy Elicker will never forget April 1, 2008 as that was the day her daughter, Lucy Stanovick, was diagnosed with Stage IV metastatic breast cancer — she was just 42 years old. Lucy was a beacon of light to all who knew her. While fighting her own health battles and raising two…...
Meet Darrell Rice: A Courageous and Inspirational Caregiver
This year marks the 13th anniversary of Carmen Rice’s survival from Glioblastoma Multiforme (GBM) – the deadliest brain cancer that is widely regarded as incurable and universally fatal. Carmen’s thirteen-year survival is nothing less than miraculous and last month, we shared her incredible story with you. Today, we’d like to…...
Dr. Jim Allison: Cancer Immunotherapy Pioneer
Szent-Györgyi Prize Winners: Then & Now The Szent-Györgyi Prize was established in honor of Nobel laureate Dr. Albert Szent-Györgyi, co-founder of NFCR, to recognize outstanding scientific achievement in the war against cancer. Ten years later, “ASG Winners: Then & Now” looks at these winners, their extraordinary contributions and how their discoveries have made possible new…...
Cancer May Metastasize Without Lymph Node Involvement
Cancer May Metastasize Without Lymph Node Involvement NFCR-funded research finds two distinct patterns of metastatic spread in human colorectal cancer (Bethesda, MD, July 13, 2017) Research by several leading scientists including Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and…...
Ally Minker: A Young Woman Determined to Make a Difference
For the third year in a row, Play4TheCure® and minor league baseball are teaming up to raise money and awareness for cutting-edge cancer research— a partnership started by National Foundation for Cancer Research (NFCR) Youth Ambassador Ally Minker. Nearly nine years ago, Matt Minker passed away from cancer. Baseball was…...
FDA Approves First Cancer Drug Based on Genetics… Not Tumor Location
Just last week, the U.S. Food and Drug Administration approved the cancer medicine— Keytruda® (generic name pembrolizumab)— to treat cancers that have a specific genetic mutation or biomarker. This is the first time a cancer treatment has been approved based on a biomarker rather than the body location where the…...
Strategic Media Partner
